Stroke. Vascular syndromes of brain in cerebrovascular diseases
Conditions
Interventions
Intervention 1: Intervention group: Anodal stimulation of the M1 and DLPFC of the involved side. The two-channel device 2-NEUROSTIM manufactured by Medina Medical Company will be used to create electr
Sponsors
Rasht University of Medical Sciences
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: First stroke Medial Cerebellar Artery (MCA) stroke The ability to verbally communicate with the therapist Patients using the Ashworth Modified Modified Scale (MMAS) to have a knee flexion muscle spasm severity of 1 or higher No history of a brain tumor Patients who do not have severe cognitive and memory disorders. To determine this, the Persian version of the Mini-Mental State Examination is used and patients must score at least 23 out of a total of 30
Exclusion criteria
Exclusion criteria: Patients with chronic neurological diseases such as Parkinson's, Alzheimer's, schizophrenia, radiculopathy, and musculoskeletal disorders, especially upper extremity movement disorders, diagnosed by a neurologist. History of seizures, previous brain surgery, heart disease and pacemaker Take drugs that change a person's cognitive status
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Motor function. Timepoint: Before the first and after last electrical stimulation. Method of measurement: Fugl meyer test.;Brain metabolite activity,. Timepoint: Before the first and after last electrical stimulation. Method of measurement: Metabolite content with Magnetic resonance imaging. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactSomaye Azarnia
Rasht University of Medical Sciences
Outcome results
None listed